Announcements Trials
Browse Landscape

Phase

Phase 1 10Phase 2 5Phase 1/2 5Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 3Nasopharyngeal Carcinoma 3Recurrence 2Non-Muscle Invasive Bladder Neoplasms 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Uterine Neoplasms 1Thromboembolism 1Stomach Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1NSCLC 1Malnutrition 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Locally Advanced Pancreatic Cancer 1Infiltrating Bladder Urothelial Carcinoma 1Immunoblastic Lymphadenopathy 1Hypoxia 1Gallbladder Neoplasms 1Cholangiocarcinoma 1

Interventions

Oxaliplatin 10Endoscopic Mucosal Resection 10Surgical Procedures, Operative 8Standard of Care 8Exercise 7Laparoscopy 6Fluorouracil 6Drug Therapy 6Sodium Chloride 5Leucovorin 5Gastroenterostomy 5Gastrectomy 5Endoscopy, Digestive System 5Saline Solution 4S 1 (combination) 4Preoperative Exercise 4Practice Guidelines as Topic 4Dietary Supplements 4Control Groups 4Biopsy 4Acupuncture Therapy 4Surveys and Questionnaires 3Ropivacaine 3Paclitaxel 3Nutrition Assessment 3Narrow Band Imaging 3Methods 3Indocyanine Green 3Hyperthermic Intraperitoneal Chemotherapy 3Hematologic Tests 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Stomach Neoplasms × Gemcitabine × Clear all
NCT05431244 2022-11-01

Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)

Samsung Medical Center

Phase NA Withdrawn
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡